GlassScriptPhysician profile
James Benjamin Angel
NPI 1306138912
$7,526.22
in general payments reported to CMS, 2019-2025
30 companies · $4,661 in 2025
The $4,661 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $43.10 · 2021: $288 · 2022: $126 · 2023: $934 · 2024: $305 · 2025: $4,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,417 · Travel and Lodging: $1,265 · Food and Beverage: $1,118 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,416.67 |
| Travel and Lodging | $1,264.72 |
| Food and Beverage | $1,118.37 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,384.41 | 2024-2025 | Nanoknife, Nanoknife |
| Intuitive Surgical, INC. | $750.00 | 2019 | |
| Procept Biorobotics Corporation | $551.22 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $358.55 | 2019-2023 | Xtandi, Myrbetriq |
| 180 Medical, INC. | $340.73 | 2019-2025 | |
| Pfizer INC. | $211.65 | 2019-2025 | |
| Axonics, INC. | $110.69 | 2020-2024 | Axonics |
| Karl Storz Endoscopy-America | $98.00 | 2024 | Hopkins |
| Boston Scientific Corporation | $90.08 | 2019-2023 | Lithovue, Rezum Generator |
| Sumitomo Pharma America, INC. | $73.31 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $65.01 | 2021-2023 | |
| Olympus America INC. | $64.89 | 2023-2025 | Bovie, Itind System |
| Janssen Biotech, INC. | $60.09 | 2020-2023 | Erleada |
| Accord Healthcare, INC. | $55.44 | 2022-2025 | |
| Convatec INC. | $42.91 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $38.14 | 2025 | Bioprotect Balloon Implant System |
| Abbvie INC. | $26.25 | 2021-2022 | |
| Endo USA, INC. | $24.69 | 2025 | Xiaflex |
| Tolmar, INC. | $23.07 | 2024 | |
| Melinta Therapeutics, LLC | $19.14 | 2019 | |
| Amgen INC. | $18.89 | 2019 | |
| Neotract INC. | $18.27 | 2019 | |
| Endo Pharmaceuticals INC. | $17.15 | 2021 | |
| Cook Medical LLC | $16.99 | 2019 | |
| Merck Sharp & Dohme LLC | $16.52 | 2024 | Bridion |
| Medtronic, INC. | $13.76 | 2022 | |
| Urovant Sciences INC | $13.11 | 2022 | |
| Coloplast Corp | $11.81 | 2019 | |
| Sagent Pharmaceuticals | $11.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$48,212.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.